Mass Tort brief
Billion-Dollar Checkbooks and Courtroom Brinkmanship
Tech platforms and chemical makers cut multibillion-dollar deals to escape bellwether juries, while federal judges push back against sweeping nationwide releases.
Mass Tort
Mass Tort
3M agreed to pay $7.35B over 9 years to settle 120,000 firefighter cancer claims — capping its largest personal injury liability from toxic forever chemicals.
BackgroundAqueous film-forming foam containing per- and polyfluoroalkyl substances was sprayed for decades by military personnel and municipal firefighters to extinguish fuel fires. These synthetic chemical compounds never degrade in human tissue and have been conclusively linked to kidney, testicular, and thyroid cancers.
- The agreement resolves individual claims coordinated in federal multidistrict litigation MDL No. 2873 in South Carolina, removing severe balance sheet exposure from unpredictable jury verdicts.
- 3M agreed to fund the $7.35 billion settlement over a 9-year schedule, preserving operating cash flow while formally drawing a line under catastrophic individual liabilities.
- The deal exclusively covers personal injury claims, leaving separate pending lawsuits concerning municipal water district cleanup costs and property damages active across federal courts.
Mass Tort
J&J secured 87.5% backing for its $5.5B talc settlement — but the deal remains stalled until plaintiffs hit the mandatory 95% sign-on threshold.
BackgroundJohnson & Johnson faces tens of thousands of lawsuits alleging its legacy talcum powder products were contaminated with asbestos and caused ovarian cancer and mesothelioma. After federal courts rejected two corporate bankruptcy attempts by J&J subsidiaries, the company shifted toward negotiating a direct pre-packaged civil settlement.
- Active lawsuits coordinated in federal multidistrict litigation MDL No. 2738 in New Jersey reached 69,376 claims, with J&J tracking 76,500 total actions nationwide.
- Lead plaintiffs' counsel reported that 66,500 claimants have formally agreed to the settlement terms, leaving the agreement 7.5 percentage points below the required threshold.
- Johnson & Johnson maintains a $9.0 billion accounting reserve for talc litigation as leadership weighs whether to waive the 95% requirement if opt-ins stall.
Mass Tort
A federal judge questioned Bayer's $7.25B Missouri Roundup deal — threatening to unravel a nationwide class settlement over releases of future cancer claims.
BackgroundBayer acquired agricultural giant Monsanto in 2018 for $63 billion, inheriting tens of thousands of product liability lawsuits alleging glyphosate in Roundup causes non-Hodgkin lymphoma. The German conglomerate has paid billions in individual jury verdicts and settlements while attempting to secure a final, binding national resolution.
- Judge Chhabria expressed concern that the proposed Missouri settlement structure unlawfully binds future cancer victims who have not yet been diagnosed, denying them constitutional due process.
- Settlement proponents representing 60% of active claims argued that federal MDL courts lack jurisdictional authority to disrupt a deal preliminarily approved by a state court.
- The proposed agreement establishes an average estimated compensation payout of $40,000 for qualifying residential users diagnosed with aggressive lymphoma before age 60.
Mass Tort
Mass Tort
Unlock the full brief
Sign in to read every signal, takeaway, and source. Free account — Apple, Google, or email.
